List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
8273-CL-0101An open-label study of the oral administration of ASP8273 in patients with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutations English


English


8273-CL-0102An open-label, phase 1 dose escalation study of oral ASP8273 in subjects with non-small-cell lung cancer (NSCLC) who have epidermal growth factor receptor (EGFR) mutations English


English


8273-CL-0112A Phase 1, Randomized, 2-period Crossover Study to Assess Bioequivalence of a Tablet Formulation versus a Capsule Formulation of ASP8273 in Subjects With Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations English


English


8273-CL-0202An open-label, study of the oral administration of ASP8273 in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor-naïve patients with non-small cell lung cancer harboring EGFR mutations English


English


NextLast

QUICK SEARCH

USEFUL LINKS